Mirajet Launches First Advertising Campaign... Targets 'Skin Booster' Audience with Model Shin Seulgi View original image

Global medical aesthetic device company JSK Biomed (hereinafter, JSK Biomed) announced on March 3 that it will officially launch the first advertising campaign for its needle-free laser jet injector, 'mirajet'.


This campaign marks the brand's first large-scale initiative and aims to expand the brand experience of mirajet to consumers who are highly interested in skin booster treatments and are carefully considering different treatment methods.


Actress Shin Seulgi has been selected as the campaign model. JSK Biomed stated, "Shin Seulgi has always shown great interest in skin aesthetics and has built a rapport with the public through her approachable and trustworthy image across various media platforms. We believe she is the ideal figure to naturally appeal to core targets who are particularly interested in skin booster treatments."

Mirajet Launches First Advertising Campaign... Targets 'Skin Booster' Audience with Model Shin Seulgi View original image

This campaign will be centered around the Gangnam area, often referred to as the 'mecca of skin aesthetics'. The company plans to increase consumer touchpoints through out-of-home (OOH) advertising in major commercial districts with high foot traffic, while simultaneously running digital advertisements to enhance online reach and repeated exposure, thereby executing integrated marketing communications (IMC) both online and offline.



A representative from JSK Biomed stated, "With the launch of this campaign, we will strengthen the unique brand experience of mirajet so that consumers not only consider skin booster treatments, but also pay attention to and choose the 'delivery method'. We plan to expand various touchpoints so that consumers contemplating skin booster treatments will naturally think of mirajet."


This content was produced with the assistance of AI translation services.

© The Asia Business Daily. All rights reserved. Unauthorized AI training and use prohibited.

Today’s Briefing